Short answer · Medically reviewed summary · Last updated: 2023-07-13
Zellweger Spectrum Disorders (ZSD) are a group of rare genetic disorders that affect various body systems. They are characterized by the impaired function of peroxisomes, which are essential for normal cell metabolism.
What is the prevalence of Zellweger Spectrum Disorders?
Prevalence of Zellweger Spectrum Disorders: how many people are affected worldwide, differences by sex and region, with sources.
Zellweger Spectrum Disorders (ZSD) are a group of rare genetic disorders that affect various body systems. They are characterized by the impaired function of peroxisomes, which are essential for normal cell metabolism. ZSD encompasses a spectrum of disorders, including Zellweger syndrome, neonatal adrenoleukodystrophy, and infantile Refsum disease.
Due to their rarity, the prevalence of Zellweger Spectrum Disorders is relatively low. It is estimated that ZSD occurs in approximately 1 in 50,000 to 100,000 live births. However, the exact prevalence may vary across different populations and regions.
ZSD typically presents in infancy or early childhood and can lead to severe neurological, liver, and kidney abnormalities. The prognosis for individuals with ZSD is generally poor, with most affected individuals experiencing significant developmental delays and a shortened lifespan.
Early diagnosis and intervention are crucial in managing ZSD. Genetic testing and clinical evaluation are essential for accurate diagnosis. Although there is currently no cure for ZSD, supportive care and symptom management can help improve the quality of life for affected individuals and their families.
